FAM168A
Basic information
Region (hg38): 11:73400487-73598189
Previous symbols: [ "KIAA0280" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FAM168A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 9 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 0 | 0 |
Variants in FAM168A
This is a list of pathogenic ClinVar variants found in the FAM168A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-73407571-T-C | not specified | Uncertain significance (Jan 03, 2024) | ||
11-73407613-G-A | not specified | Uncertain significance (May 26, 2023) | ||
11-73407616-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
11-73409529-C-T | not specified | Uncertain significance (Nov 15, 2021) | ||
11-73409535-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
11-73409546-G-A | not specified | Uncertain significance (Jan 16, 2025) | ||
11-73411443-G-A | not specified | Uncertain significance (Aug 14, 2024) | ||
11-73411471-A-T | not specified | Uncertain significance (Oct 16, 2024) | ||
11-73430731-T-C | not specified | Uncertain significance (Jul 14, 2023) | ||
11-73468417-T-C | not specified | Uncertain significance (Jan 26, 2025) | ||
11-73468453-C-T | not specified | Uncertain significance (Sep 15, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FAM168A | protein_coding | protein_coding | ENST00000356467 | 6 | 197703 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.987 | 0.0133 | 120145 | 0 | 1 | 120146 | 0.00000416 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.66 | 89 | 145 | 0.612 | 0.00000800 | 1496 |
Missense in Polyphen | 22 | 42.341 | 0.51959 | 456 | ||
Synonymous | 0.143 | 62 | 63.4 | 0.977 | 0.00000426 | 496 |
Loss of Function | 3.35 | 0 | 13.1 | 0.00 | 6.42e-7 | 140 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000316 | 0.0000316 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: In cancer context, protects cells from induced-DNA damage and apoptosis. Acts, at least in part, through PI3K/AKT/NFKB signaling pathway and by preventing POLB degradation. Decreases POLB ubiquitation and stabilizes its protein levels. {ECO:0000269|PubMed:21334329, ECO:0000269|PubMed:21603883, ECO:0000269|PubMed:23251525, ECO:0000269|PubMed:25260657}.;
- Disease
- DISEASE: Note=Associated with cisplatin (DDP)-resistance and radioresistance in the treatment of lung cancer as well as oral squamous cell carcinoma and poor clinical outcome in patients. {ECO:0000269|PubMed:21334329, ECO:0000269|PubMed:21603883, ECO:0000269|PubMed:23251525, ECO:0000269|PubMed:25260657}.;
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- loftool
- 0.0716
- rvis_EVS
- -0.3
- rvis_percentile_EVS
- 32.62
Haploinsufficiency Scores
- pHI
- 0.335
- hipred
- Y
- hipred_score
- 0.654
- ghis
- 0.650
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.430
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fam168a
- Phenotype
Gene ontology
- Biological process
- positive regulation of base-excision repair
- Cellular component
- Molecular function
- protein binding